Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 HKD | -2.38% | +1.23% | +0.49% |
Sales 2023 | 10.53B 1.35B | Sales 2024 * | 12.06B 1.54B | Capitalization | 14.39B 1.84B |
---|---|---|---|---|---|
Net income 2023 | 1.88B 240M | Net income 2024 * | 2.44B 312M | EV / Sales 2023 | 1.37 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.19 x |
P/E ratio 2023 |
7.63
x | P/E ratio 2024 * |
6.1
x | Employees | - |
Yield 2023 * |
2.61% | Yield 2024 * |
3.09% | Free-Float | 28.4% |
Latest transcript on Grand Pharmaceutical Group Limited
1 day | -2.38% | ||
1 week | +1.23% | ||
Current month | +14.48% | ||
1 month | +12.30% | ||
3 months | +0.98% | ||
6 months | -1.67% | ||
Current year | +0.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 34 | 19-03-31 |
Tin Chung Foo
SEC | Corporate Secretary | 56 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 61 | 05-03-20 |
Ye Bi Hu
BRD | Director/Board Member | 60 | 18-12-30 |
Geng Pei
BRD | Director/Board Member | 64 | 11-05-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.86% | 4 M€ | -27.92% | ||
0.01% | 115 M€ | +4.54% | - | |
0.01% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.11 | -2.38% | 2 625 000 |
24-03-27 | 4.21 | +2.18% | 6,327,500 |
24-03-26 | 4.12 | +4.30% | 7,556,000 |
24-03-25 | 3.95 | -2.47% | 3,830,500 |
24-03-22 | 4.05 | -0.25% | 5,498,000 |
Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.49% | 1.88B | |
+35.11% | 701B | |
+26.24% | 571B | |
+1.19% | 381B | |
+20.40% | 334B | |
+16.95% | 319B | |
+0.98% | 210B | |
+2.26% | 210B | |
-6.44% | 201B | |
-3.30% | 157B |